Evoke Pharma Inc (EVOK):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Evoke Pharma Inc (EVOK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7979
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions for nausea, bloating, upper abdominal pain, prolonged fullness, early satiety and vomiting. The company operates through other commercial organizations and external consultants to develop novel product candidates. It also develops programs with associated clinical data, products containing previously approved compounds, and others. Evoke Pharma is headquartered in Solana Beach, California, the US.

Evoke Pharma Inc (EVOK) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 12
Evoke Pharma Enters into Partnership with Spaulding Clinical Research 13
Equity Offering 14
Evoke Pharma Plans to Raise up to USD16 Million in Public Offering of Shares 14
Evoke Pharma Raises USD8 Million in Public Offering of Shares 15
Evoke Pharma Raises USD4.5 Million in Registered Direct Offering 16
Evoke Pharma to Raise USD10 Million in Registered Direct Offering 18
Evoke Pharma Raises USD5 Million in Public Offering of Shares 19
Evoke Pharma to Raise Funds through Public Offering of Shares 20
Evoke Pharma Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$29 Million 21
Evoke Pharma Inc – Key Competitors 23
Evoke Pharma Inc – Key Employees 24
Evoke Pharma Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
Aug 09, 2018: Evoke Pharma reports second quarter 2018 results and recent highlights 26
May 14, 2018: Evoke Pharma Reports First Quarter 2018 Results and Highlights 27
Mar 07, 2018: Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights 28
Nov 14, 2017: Evoke Pharma Reports Third Quarter 2017 Results and Highlights 29
Aug 14, 2017: Evoke Pharma Reports Second Quarter 2017 Results and Highlights 30
May 15, 2017: Evoke Pharma Reports First Quarter 2017 Results 31
May 15, 2017: Evoke Pharma Q1 net loss increases 32
Mar 15, 2017: Evoke Pharma Reports Fourth Quarter and Full Year 2016 Results 33
Product News 34
10/27/2017: Evoke Pharma Announces Conference Call to Review the Successful Results of Comparative Exposure Pharmacokinetic Study for Gimoti 34
10/23/2017: Evoke Pharma Announces Positive Topline Results from Comparative Exposure Pharmacokinetic Study for Gimoti 35
10/04/2017: Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference 36
09/05/2017: Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference 37
05/15/2017: Evoke Pharma Provides Update on Gimoti 38
02/15/2018: Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti 39
Product Approvals 40
Sep 12, 2017: Evoke Pharma Completes Dosing for Gimoti Comparative Exposure Pharmacokinetic Study 40
Aug 14, 2017: Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti 41
May 31, 2017: Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti 42
Apr 04, 2017: Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharma’s Proposed Comparative Exposure PK Trial for Gimoti NDA 43
Feb 15, 2017: FDA Exempts Evoke from Requirement for Human Factor Validation Study 44
Clinical Trials 45
May 10, 2017: Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017 45
Mar 21, 2017: Evoke Pharmas Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017 46
Jan 09, 2017: Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference 47
Jan 04, 2017: Evoke Provides Additional Data Demonstrating Statistically Significant Benefit for Gimoti in Moderate to Severe Patients in Phase 3 Diabetic Gastroparesis Trial 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 12
Evoke Pharma Enters into Partnership with Spaulding Clinical Research 13
Evoke Pharma Plans to Raise up to USD16 Million in Public Offering of Shares 14
Evoke Pharma Raises USD8 Million in Public Offering of Shares 15
Evoke Pharma Raises USD4.5 Million in Registered Direct Offering 16
Evoke Pharma to Raise USD10 Million in Registered Direct Offering 18
Evoke Pharma Raises USD5 Million in Public Offering of Shares 19
Evoke Pharma to Raise Funds through Public Offering of Shares 20
Evoke Pharma Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$29 Million 21
Evoke Pharma Inc, Key Competitors 23
Evoke Pharma Inc, Key Employees 24

List of Figures
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Evoke Pharma Inc (EVOK):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kering SA:企業のM&A・事業提携・投資動向
    Kering SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kering SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C):企業の戦略・SWOT・財務情報
    The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report Summary The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Viet Capital Securities Joint Stock Company (VCI):企業の財務・戦略的SWOT分析
    Viet Capital Securities Joint Stock Company (VCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Nielsen Holdings plc (NLSN):企業の財務・戦略的SWOT分析
    Nielsen Holdings plc (NLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Zarubezhneft:石油・ガス:M&Aディール及び事業提携情報
    Summary Zarubezhneft is an oil and gas company that explores and develops oil and gas properties. The company constructs, operates and designs oil refineries, tank farms and pipeline systems for storage, transportation and marketing operations. Its services include engineering, design and account ev …
  • Grupa Lotos SA (LTS):企業の財務・戦略的SWOT分析
    Grupa Lotos SA (LTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Addex Therapeutics Ltd (ADXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Addex Therapeutics Ltd (Addex) develops orally available, small molecule allosteric modulators for neurological disorders. The company’s product pipeline consists of its lead products, dipraglurant (mGluR5 negative allosteric modulator or NAM) to treat Parkinson’s disease levodopa-induced dy …
  • VWR Corp:医療機器:M&Aディール及び事業提携情報
    Summary VWR Corp (VWR), a subsidiary of Avantor Performance Materials Inc, is a medical equipment company that distributes laboratory products, and provides services and solutions. The company offers product such chemicals, reagents, consumables, durable products, scientific equipment and instrument …
  • Liechtensteinische Landesbank Private Clients:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank Private Clients - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Schindler Holding Ltd (SCHP):企業の財務・戦略的SWOT分析
    Schindler Holding Ltd (SCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Jumbo SA:企業の戦略・SWOT・財務分析
    Jumbo SA - Strategy, SWOT and Corporate Finance Report Summary Jumbo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Toyo Seikan Group Holdings, Ltd.:企業の戦略・SWOT・財務分析
    Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cosmo Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Cosmo Oil Co Ltd (Cosmo Oil), a subsidiary of Cosmo Energy Holdings Co Ltd, procures oil and refines, distributes, imports and exports petroleum products and petrochemical products. The company operates Chiba, Yokkaichi and Sakai refineries. These refineries produce petroleum products such a …
  • Beacon Industries Inc.:企業の戦略・SWOT・財務分析
    Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mitsubishi UFJ Financial Group Inc:企業のM&A・事業提携・投資動向
    Mitsubishi UFJ Financial Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi UFJ Financial Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Tampa Electric Co:電力:M&Aディール及び事業提携情報
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • Intellia Therapeutics Inc (NTLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • BioClinica Inc:企業の戦略的SWOT分析
    BioClinica Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆